Insider · CIK 0001517892

Krizman Anthony

Reports to the SEC for 1 company · SCHAUMBURG, IL

sec.gov

Transactions

Companies

Filings

CIK

0001517892

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-08-29	Sagent Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−7,097 sh	$21.75	−$154K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−8,556 sh	$21.75	−$186K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Stock Option to BuyD Disposition to Issuer	Director	DDisposition to Issuer	−6,379 sh	$10.15	−$64.7K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−760 sh	$21.75	−$16.5K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,860 sh	$21.75	−$40.5K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,381 sh	$21.75	−$30K	0
2016-08-29	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−691 sh	$21.75	−$15K	0
2016-02-25	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+230 sh	—	—	7,097
2016-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−230 sh	—	—	691
2016-02-25	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+460 sh	—	—	6,867
2016-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−460 sh	—	—	1,381
2016-02-22	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+567 sh	—	—	6,407
2016-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+8,556 sh	—	—	8,556
2016-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−567 sh	—	—	0
2016-02-21	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−760 sh	—	—	760
2016-02-21	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+760 sh	—	—	5,840
2016-02-18	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+930 sh	—	—	5,080
2016-02-18	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−930 sh	—	—	1,860
2015-04-09	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+921 sh	—	—	921
2015-02-25	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+1,841 sh	—	—	1,841
2015-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−567 sh	—	—	567
2015-02-22	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+567 sh	—	—	4,150
2015-02-21	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−760 sh	—	—	1,520
2015-02-21	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+760 sh	—	—	3,583
2015-02-18	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+930 sh	—	—	2,823
2015-02-18	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−930 sh	—	—	2,790
2014-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−567 sh	—	—	1,134
2014-02-22	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+567 sh	—	—	1,893
2014-02-21	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+759 sh	—	—	1,326
2014-02-21	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−759 sh	—	—	2,280
2014-02-18	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+3,720 sh	—	—	3,720
2013-02-22	Sagent Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+567 sh	—	—	567
2013-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−567 sh	—	—	1,701
2013-02-21	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+3,039 sh	—	—	3,039
2012-02-22	Sagent Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,268 sh	—	—	2,268

Recent filings

Accepted (ET)
Aug 314
Sagent Pharmaceuticals, Inc.0000899243-16-028313
SEC(opens sec.gov)
Feb 254
Sagent Pharmaceuticals, Inc.0001562180-16-001810
SEC(opens sec.gov)
Feb 234
Sagent Pharmaceuticals, Inc.0001562180-16-001770
SEC(opens sec.gov)
Feb 224
Sagent Pharmaceuticals, Inc.0001562180-16-001730
SEC(opens sec.gov)
Apr 134
Sagent Pharmaceuticals, Inc.0001181431-15-005743
SEC(opens sec.gov)
Feb 274
Sagent Pharmaceuticals, Inc.0001181431-15-003485
SEC(opens sec.gov)

Companies

Sagent Pharmaceuticals, Inc.Director

Address

C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700

SCHAUMBURG, IL, 60195